LONG‐TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS‐2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMAPaolo F. Caimi, Carmelo Carlo‐Stella, Juan Pablo Alderuccio et al.|Hematological Oncology|2023Cited by 1